Literature DB >> 22664577

Plasma oxidative stress parameters in men and women with early stage Alzheimer type dementia.

M C Puertas1, J M Martínez-Martos, M P Cobo, M P Carrera, M D Mayas, M J Ramírez-Expósito.   

Abstract

It is well known that oxidative stress is one of the earliest events in Alzheimer's disease pathogenesis, indicating that may play a key role in this disease. In our study, we measured the levels of oxidative stress indicators (TBARS and protein carbonyls content) and the non-enzymatic (glutathione (GSH) and oxidized glutathione (GSSG)) and enzymatic (glutathione peroxidase (GPx), catalase (CAT) and superoxide dismutase (SOD)) defense systems in the plasma of 46 patients diagnosed of ATD and 46 age-matched controls. We found decreased levels in total GSH in ATD patients, although healthy control women showed lower levels of total GSH than healthy control men. On the contrary, we found increased levels of TBARS and carbonyl groups content in ATD patients in both genders. The activity of the plasma antioxidant enzymes showed no changes for SOD activity in ATD patients, independently of the gender, although western blot analysis showed an increase in SOD-1 protein. CAT activity was also decreased in ATD patients, although this decrease is mainly due to the decrease found in men but not in women. However, western blot analysis did not show differences in CAT protein between controls and ATD patients. Finally, a decrease of GPx activity was found in ATD patients in both genders. However, as with CAT protein, western blot analysis did not show differences in GPx protein between controls and ATD patients. Our results suggest that there is a defect in the antioxidant defense system that is incapable of responding to increased free radical production, which may lead to oxidative damage and the development of the pathological alterations that characterize the neurodegenerative disorder of patients with ATD. Thus, oxidative damage could be one important aspect for the onset of ATD and oxidative stress markers could be useful to diagnose the illness in their earliest stages through both non-invasive, reliable and cost-affordable methods.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22664577     DOI: 10.1016/j.exger.2012.05.019

Source DB:  PubMed          Journal:  Exp Gerontol        ISSN: 0531-5565            Impact factor:   4.032


  35 in total

1.  Increased susceptibility to oxidative death of lymphocytes from Alzheimer patients correlates with dementia severity.

Authors:  Daniela P Ponce; Felipe Salech; Carol D SanMartin; Monica Silva; Chengjie Xiong; Catherine M Roe; Mauricio Henriquez; Andrew F Quest; Maria I Behrens
Journal:  Curr Alzheimer Res       Date:  2014       Impact factor: 3.498

Review 2.  Biomarkers of lipid peroxidation in Alzheimer disease (AD): an update.

Authors:  Melissa A Bradley-Whitman; Mark A Lovell
Journal:  Arch Toxicol       Date:  2015-04-18       Impact factor: 5.153

3.  Dietary lipid unsaturation influences survival and oxidative modifications of an amyotrophic lateral sclerosis model in a gender-specific manner.

Authors:  Daniel Cacabelos; Victoria Ayala; Omar Ramírez-Nunez; Ana Belen Granado-Serrano; Jordi Boada; Jose C E Serrano; Rosanna Cabré; Gisela Nadal-Rey; Maria Josep Bellmunt; Isidro Ferrer; Reinald Pamplona; Manuel Portero-Otin
Journal:  Neuromolecular Med       Date:  2014-07-01       Impact factor: 3.843

Review 4.  Neuroprotective mechanisms of astaxanthin: a potential therapeutic role in preserving cognitive function in age and neurodegeneration.

Authors:  Bethany Grimmig; Seol-Hee Kim; Kevin Nash; Paula C Bickford; R Douglas Shytle
Journal:  Geroscience       Date:  2017-02-13       Impact factor: 7.713

5.  Relationship of cognitive performance with prolidase and oxidative stress in Alzheimer disease.

Authors:  Adalet Arikanoglu; Esref Akil; Sefer Varol; Yavuz Yucel; Hatice Yuksel; Mehmet Ugur Cevik; Yilmaz Palanci; Fatma Unan
Journal:  Neurol Sci       Date:  2013-03-12       Impact factor: 3.307

6.  Selenium Protects Retinal Cells from Cisplatin-Induced Alterations in Carbohydrate Residues.

Authors:  Dilek Akşit; Alper Yazıcı; Hasan Akşit; Esin S Sarı; Arzu Yay; Onur Yıldız; Adil Kılıç; Sıtkı S Ermiş; Kamil Seyrek
Journal:  Balkan Med J       Date:  2016-07-01       Impact factor: 2.021

7.  Antioxidant status and APOE genotype as susceptibility factors for neurodegeneration in Alzheimer's disease and vascular dementia.

Authors:  Giancarlo Zito; Renato Polimanti; Valentina Panetta; Mariacarla Ventriglia; Carlo Salustri; Maria Cristina Siotto; Filomena Moffa; Claudia Altamura; Fabrizio Vernieri; Domenico Lupoi; Emanuele Cassetta; Paolo M Rossini; Rosanna Squitti
Journal:  Rejuvenation Res       Date:  2013-02       Impact factor: 4.663

8.  Benzothiazole aniline tetra(ethylene glycol) and 3-amino-1,2,4-triazole inhibit neuroprotection against amyloid peptides by catalase overexpression in vitro.

Authors:  Amrutha Chilumuri; Mark Odell; Nathaniel G N Milton
Journal:  ACS Chem Neurosci       Date:  2013-09-09       Impact factor: 4.418

9.  Regular cigarette smoking influences the transsulfuration pathway, endothelial function, and inflammation biomarkers in a sex-gender specific manner in healthy young humans.

Authors:  Ilaria Campesi; Ciriaco Carru; Angelo Zinellu; Stefano Occhioni; Manuela Sanna; Mario Palermo; Giancarlo Tonolo; Giuseppe Mercuro; Flavia Franconi
Journal:  Am J Transl Res       Date:  2013-08-15       Impact factor: 4.060

Review 10.  Therapeutic potential of astaxanthin and superoxide dismutase in Alzheimer's disease.

Authors:  Vyshnavy Balendra; Sandeep Kumar Singh
Journal:  Open Biol       Date:  2021-06-30       Impact factor: 6.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.